India’s Coronary Stent Market Set to Reach USD 1.3 billion by 2035 Amid Rising Cardiac Care Innovations

The industrial analysis of coronary stents in India highlights a promising trajectory for the next decade, with the market projected to expand from USD 0.9 billion in 2025 to USD 1.3 billion by 2035. This growth reflects a compound annual growth rate (CAGR) of 3.5% and is driven by the increasing prevalence of cardiovascular diseases, rising awareness of early interventions, and expanding healthcare infrastructure across the country. As India continues to strengthen its position in cardiac care, both established and emerging manufacturers are investing in innovative technologies to meet the rising demand for advanced coronary interventions.

Market Dynamics and Value Forecast

Between 2025 and 2035, India’s coronary stent market is expected to experience steady growth, with drug-eluting stents maintaining dominance, accounting for 52.4% of the product type segment. The market expansion is supported by government initiatives improving accessibility to cardiac care, enhanced diagnostic capabilities, and the availability of skilled interventional cardiologists. Technological advancements, including bioresorbable and polymer-coated stents, have further elevated patient outcomes while minimizing post-procedural complications, making coronary stents increasingly preferred among healthcare providers.

Full Market Report available for delivery. For purchase or customization, please request here: https://www.futuremarketinsights.com/reports/sample/rep-in-1485

Segmental Insights: Product Types and Raw Materials

Drug-eluting stents have emerged as the leading product type in India, primarily due to their effectiveness in reducing restenosis rates and improving long-term patient outcomes. Hospitals and cardiac care centers increasingly procure these stents, with adoption further reinforced by favorable reimbursement policies and patient preference. International and domestic manufacturers are strategically collaborating to improve distribution networks, ensuring availability even in tier-2 and tier-3 cities.

In terms of raw materials, cobalt chromium remains the preferred choice, representing 41.7% of the market. Its strength, biocompatibility, and corrosion resistance make it ideal for stent manufacturing. Advances in fabrication and coating adherence techniques have made cobalt chromium a standard, while ongoing material innovations promise cost optimization and performance improvements in the coming years. Polymer-coated stents are also gaining traction due to their biocompatibility and affordability compared to drug-eluting stents, offering doctors and patients greater flexibility and choice in treatment.

End-User Adoption and Hospital Segment Leadership

Hospitals dominate the coronary stent adoption landscape in India, accounting for 61.3% of the end-user category. The widespread presence of cardiac care units, trained interventional cardiologists, and advanced stent technology integration has strengthened hospital adoption. Private and public hospital expansions, particularly in urban and semi-urban regions, are enhancing accessibility to life-saving procedures. Insurance coverage and patient preference for hospital-based interventions further solidify this segment’s leadership, ensuring sustained growth for coronary stent adoption across India.

Drivers of Coronary Stent Demand

The rise in cardiovascular disorders remains a significant factor driving market expansion. Non-communicable diseases, including heart disease, account for a major share of fatalities in India, with lifestyle factors, stress, and dietary changes contributing to the increasing prevalence. The country’s aging population further accelerates demand, as older adults are more susceptible to coronary artery disease, necessitating interventions such as percutaneous coronary interventions and angioplasty procedures.

Innovations in stent technology, particularly drug-eluting and bioresorbable stents, are transforming cardiac care in India. These devices not only provide immediate treatment but also minimize long-term complications, resulting in better patient outcomes and heightened adoption rates. Government initiatives, including the inclusion of coronary stents in the National List of Essential Medicines and programs like Ayushman Bharat, have made stents more affordable, leading to a 30–40% increase in usage and positioning India as a growing hub for cardiac interventions.

Historical Adoption and Future Outlook

Between 2020 and 2025, the adoption of coronary stents in India grew from USD 657.5 million to USD 810.6 million, reflecting a CAGR of 4.1%. Looking ahead, the market is forecasted to rise from USD 0.9 billion in 2025 to USD 1.213 billion by 2035, with a slightly moderated CAGR of 3.7%. While market saturation may slow growth, increasing health awareness, expanded insurance coverage, and FDI inflows into healthcare are expected to sustain steady adoption. Telemedicine and remote monitoring technologies are also changing cardiac care delivery, improving procedural planning and patient follow-up, which further enhances stent adoption in India.

Emerging Trends in Coronary Stent Technology

Nanotechnology holds promise in creating next-generation stents with enhanced drug delivery capabilities and superior biocompatibility. Advanced imaging and 3D printing technologies are enabling patient-specific stent customization, improving procedural success rates. Additionally, integration with AI and big data analytics could allow predictive models for personalized interventions, revolutionizing the way interventional cardiologists prescribe and implement stent therapies. Holistic patient care strategies combining stent placement with lifestyle, nutrition, and mental health support are also emerging as potential growth drivers.

Request Market Research Draft Report: https://www.futuremarketinsights.com/reports/brochure/rep-in-1485

Competitive Landscape and Key Players

The Indian coronary stent market is moderately fragmented, with several established and emerging players competing for market share. Leading companies such as Abbott Laboratories, Medtronic, Inc., Biosensors Inc., and Boston Scientific Inc. have invested heavily in research and development, advanced stent design, and pricing strategies that enhance accessibility without compromising quality. Emerging domestic players, such as Translumina, have introduced innovations like VIVO ISAR, a dual-drug polymer-free coated stent, demonstrating India’s potential to develop cutting-edge cardiovascular solutions. Boston Scientific and Medtronic have simultaneously launched advanced drug-eluting stents with sophisticated delivery mechanisms, reinforcing global competitiveness in India’s market.

Opportunities and Challenges

While opportunities abound, the industry faces challenges such as competition from alternative therapies, including medications and lifestyle modifications, as well as shortages of trained interventional cardiologists. Nevertheless, the increasing adoption of drug-eluting and polymer-coated stents, coupled with government support and medical tourism, continues to propel market growth. India’s combination of affordable, world-class cardiac care, along with continuous technological advancement, positions the country as a preferred destination for both domestic and international patients.

Related Reports:

Neurovascular Guidewires Market: https://www.futuremarketinsights.com/reports/neurovascular-guidewires-market

Mucus Clearance Devices Market: https://www.futuremarketinsights.com/reports/mucus-clearance-devices-market

Home Sleep Screening Devices Market: https://www.futuremarketinsights.com/reports/home-sleep-screening-devices-market

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:     

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com

Website: https://www.futuremarketinsights.com

LinkedIn| Twitter| Blogs | YouTube